Peptide inhibitors of LFA-1/ICAM-1 interaction
US6630447B2 · kind B2 · utility
3Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 16, 2001 |
| Grant date | Oct 7, 2003 |
| Priority date | — |
| Expiry date | Jan 16, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cyclic peptides inhibit LFA-1 interaction with ICAM-1 and are useful in treatment of hematopoietic neoplasms and in adjunct therapy in prevention of retinoic acid syndrome and diseases involving emigration of leukocytes into organ tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.